Data Foundry

Drug recalls 2019

Dextroamphetamine Sacharate — Class II drug recall D-0143-2020

Terminated recall by Aurobindo Pharma USA Inc., reported 2019-10-23, distributed nationwide. Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thick

Recall numberD-0143-2020
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAurobindo Pharma USA Inc., East Windsor, NJ, United States
Recall initiated2019-09-19
Classified2019-10-15
Reported by FDA2019-10-23
Terminated2023-04-04
DistributedNationwide (US)
Reason classespotency, specification failure
NDC13107-0068, 13107-0068-01, 13107-0068-05, 13107-0068-25, 13107-0068-50, 13107-0068-99, 13107-0069, 13107-0069-01, 13107-0069-05, 13107-0069-25, 13107-0069-50, 13107-0069-99, 13107-0070, 13107-0070-01, 13107-0070-05, 13107-0070-25, 13107-0070-50, 13107-0070-99, 13107-0071, 13107-0071-01, 13107-0071-05, 13107-0071-25, 13107-0071-50, 13107-0071-99, 13107-0072 and 17 more
Lot numbers07319032A1
Expiration dates2021-02

Product

Dextroamphetamine Sacharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Mixed Salts of a single Entity Amphetamine Product), 20mg, 100-count bottle, RX Only, Distributed by: Aurobindo Pharma USA Inc., Dayton, NJ 08810, NDC 13107-073-01

Reason for recall

Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0143-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.